Toggle navigation
Home
Search
Services
Blog
Contact
About
Analysis of Anti-Cancer Chemicals and Phamaceutical Formulations
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Promoting Lifestyle Change via Tailored mHealth to Improve Health
Identifying and Disseminating Substance, Treatment, and Strategy (STS) Recommendations to AIDS Service Organizations
In-utero exposure to psychotropic medications and the risk of neurodevelopmental disorders
Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia
Retinoic Acid and Cyclic Amp in Breast Cancer
Recently added grants:
Core 03: Tumor Imaging Metrics
Therapeutic potential of antitumorigenic soluble MET variants induced by splicing interference
Synthesizing Image-derived Heterogeneity with Genomic measurements for Assessing Disease Aggressiveness in Lower Grade Gliomas
Shared Resource 04 Cancer Proteomics
Molecular Dissection of Seizure Microenvironment in Malignant Glioma
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N02CM72202-2-0-1
Application #
7590582
Study Section
Project Start
2007-06-01
Project End
2012-05-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N02 CA
Analysis of Anti-Cancer Chemicals and Phamaceutical Formulations
/ Research Triangle Institute
$688,286
NIH 2007
N01 CA
Analysis of Anti-Cancer Chemicals and Pharmaceutical Formulations
Hines, John /
$622,262
NIH 2007
N01 CA
Analysis of Anti-Cancer Chemicals and Phamaceutical Formulations
/
Comments
Be the first to comment on this grant